[{"address1": "150 West 4th Ave", "city": "Vancouver", "state": "BC", "zip": "V5Y 1G6", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 596, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 49, "title": "CEO, President & Chairperson", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 746836, "exercisedValue": 210706, "unexercisedValue": 2408685}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 671720, "exercisedValue": 0, "unexercisedValue": 12299500}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 39, "title": "CTO & Director", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 667706, "exercisedValue": 230210, "unexercisedValue": 1260000}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D., M.Sc.", "age": 54, "title": "Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 685080, "exercisedValue": 0, "unexercisedValue": 3502170}, {"maxAge": 1, "name": "Marcie  Thiessen CPA, CGA", "title": "Senior Director of Finance & Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Murray  McCutcheon Ph.D.", "title": "Senior Vice President of Partnering", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Aubuchon B.A., M.B.A.", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 684813, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Clarke M.A.I.C.D., Ph.D.", "title": "Senior Vice President of Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 4.48, "open": 4.855, "dayLow": 4.8023, "dayHigh": 5.82, "regularMarketPreviousClose": 4.48, "regularMarketOpen": 4.855, "regularMarketDayLow": 4.8023, "regularMarketDayHigh": 5.82, "payoutRatio": 0.0, "beta": 0.36, "forwardPE": -7.80303, "volume": 18077233, "regularMarketVolume": 18077233, "averageVolume": 5760680, "averageVolume10days": 6883070, "averageDailyVolume10Day": 6883070, "bid": 5.11, "ask": 5.17, "bidSize": 18, "askSize": 18, "marketCap": 1537197696, "fiftyTwoWeekLow": 1.891, "fiftyTwoWeekHigh": 5.82, "priceToSalesTrailing12Months": 66.50505, "fiftyDayAverage": 2.9612, "twoHundredDayAverage": 2.796475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 486383392, "profitMargins": 0.0, "floatShares": 202402451, "sharesOutstanding": 298484992, "sharesShort": 26518430, "sharesShortPriorMonth": 22514981, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0888, "heldPercentInsiders": 0.22968, "heldPercentInstitutions": 0.44787, "shortRatio": 4.66, "shortPercentOfFloat": 0.1153, "impliedSharesOutstanding": 298484992, "bookValue": 3.427, "priceToBook": 1.5027721, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -167868000, "trailingEps": -0.56, "forwardEps": -0.66, "enterpriseToRevenue": 21.043, "enterpriseToEbitda": -2.104, "52WeekChange": 0.4883721, "SandP52WeekChange": 0.13161862, "quoteType": "EQUITY", "currentPrice": 5.15, "targetHighPrice": 17.0, "targetLowPrice": 5.0, "targetMeanPrice": 8.42857, "targetMedianPrice": 8.0, "recommendationKey": "none", "numberOfAnalystOpinions": 7, "totalCash": 605265984, "totalCashPerShare": 2.028, "ebitda": -231196000, "totalDebt": 67847000, "quickRatio": 8.863, "currentRatio": 10.146, "totalRevenue": 23114000, "debtToEquity": 6.632, "revenuePerShare": 0.078, "returnOnAssets": -0.12936, "returnOnEquity": -0.15595001, "grossProfits": -147354000, "freeCashflow": -189059504, "operatingCashflow": -78402000, "revenueGrowth": -0.575, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -14.79575, "financialCurrency": "USD", "symbol": "ABCL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "PREPRE", "shortName": "AbCellera Biologics Inc.", "longName": "AbCellera Biologics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "postMarketChangePercent": 3.6893215, "postMarketPrice": 5.34, "postMarketChange": 0.19000006, "regularMarketChange": 0.67, "regularMarketDayRange": "4.8023 - 5.82", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 5760680, "fiftyTwoWeekLowChange": 3.259, "fiftyTwoWeekLowChangePercent": 1.7234268, "fiftyTwoWeekRange": "1.891 - 5.82", "fiftyTwoWeekHighChange": -0.6700001, "fiftyTwoWeekHighChangePercent": -0.115120284, "fiftyTwoWeekChangePercent": 48.837208, "corporateActions": [], "postMarketTime": 1753142273, "regularMarketTime": 1753128000, "exchange": "NMS", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 14.9554, "regularMarketPrice": 5.15, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "earningsCallTimestampStart": 1754600400, "earningsCallTimestampEnd": 1754600400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.56, "epsForward": -0.66, "epsCurrentYear": -0.645, "priceEpsCurrentYear": -7.9844966, "fiftyDayAverageChange": 2.1888, "fiftyDayAverageChangePercent": 0.7391598, "twoHundredDayAverageChange": 2.3535252, "twoHundredDayAverageChangePercent": 0.84160423, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "cryptoTradeable": false, "displayName": "AbCellera Biologics", "trailingPegRatio": null, "__fetch_time": "2025-07-22"}]